XML 34 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1
EMPLOYEE STOCK PLANS
3 Months Ended
Dec. 29, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
EMPLOYEE STOCK PLANS
EMPLOYEE STOCK PLANS
The table below summarizes the share-based compensation expense recognized for employee stock awards and employee stock purchase plan shares:
 
Three Months Ended
(In millions)
December 29,
2017
 
December 30,
2016
Cost of revenues - Product
$
0.7

 
$
0.8

Cost of revenues - Service
1.0

 
1.0

Research and development
1.2

 
1.2

Selling, general and administrative
7.8

 
7.2

Total share-based compensation expense
$
10.7

 
$
10.2

Income tax benefit for share-based compensation
$
(2.1
)
 
$
(3.0
)

 
The Company adopted new accounting guidance in the three months ended December 29, 2017 where it elected to change its accounting policy to account for forfeitures as they occur rather than estimating expected forfeitures. Share based compensation expense for the three months ended December 30, 2016 was recorded net of estimated forfeitures. See Note 1, "Summary of Significant Accounting Policies" for further information.

The fair value of options granted was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions: 
 
Three Months Ended
 
December 29,
2017
 
December 30,
2016
Employee Stock Option Plans
 
 
 
Expected term (in years)
3.82

 
4.13

Risk-free interest rate
1.9
%
 
1.4
%
Expected volatility
18.7
%
 
20.5
%
Expected dividend
%
 
%
Weighted average fair value at grant date
$
19.45

 
$
15.44



The option component of employee stock purchase plan shares was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions: 
 
Three Months Ended
 
December 29,
2017
 
December 30,
2016
Employee Stock Purchase Plan
 
 
 
Expected term (in years)
0.50

 
0.50

Risk-free interest rate
1.2
%
 
0.5
%
Expected volatility
17.9
%
 
22.3
%
Expected dividend
%
 
%
Weighted average fair value at grant date
$
20.97

 
$
19.37



A summary of share-based awards available for grant is as follows:
(In millions)
Shares Available for Grant
Balance at September 29, 2017
2.5

Granted
(0.8
)
Cancelled or expired
0.3

Balance at December 29, 2017
2.0


 
For purposes of the total number of shares available for grant under the Fourth Amended 2005 Plan, any shares subject to awards of stock options and performance stock options are counted against the available-for-grant limit as one share for every one share subject to the award. Awards other than stock options and performance stock options are counted against the available-for-grant limit as 2.6 shares for every one share awarded on or after February 9, 2012. The shares available for grant limit is further adjusted to reflect a maximum payout that could be issued for each performance grant. The maximum payouts that could be issued for each performance grant are 2.0 shares beginning in fiscal year 2018, 1.75 shares in fiscal years 2017 and 2016, and 2.0 shares in fiscal year 2015. All awards may be subject to restrictions on transferability and continued employment as determined by the Compensation and Management Development Committee.
Activity under the Company’s employee stock plans related to stock options is presented below: 
 
Options Outstanding
(In millions, except per share amounts)
Number of
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Term (in years)
 
Aggregate
Intrinsic
Value
 (1)
Balance at September 29, 2017
2.3

 
$
74.08

 
 
 
 
Granted
0.2

 
109.05

 
 
 
 
Cancelled or expired (2)

 
75.38

 
 
 
 
Exercised
(0.2
)
 
67.62

 
 
 
 
Balance at December 29, 2017
2.3

 
$
78.45

 
4.8
 
$
74.3

 
 
 
 
 
 
 
 
Exercisable at December 29, 2017
1.1

 
$
72.45

 
3.7
 
$
41.2



(1) 
The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of VMS common stock of $111.15 as of December 29, 2017, the last trading date of the first quarter of fiscal year 2018, and which represents the amount that would have been received by the option holders had all option holders exercised their options and sold the shares received upon exercise as of that date.
(2) 
The cancelled and expired shares were not material for disclosure.
As of December 29, 2017, there was $12.0 million of total unrecognized compensation expense related to stock options granted under the Company's employee stock plans. This unrecognized compensation expense is expected to be recognized over a weighted average period of 2.2 years.
The activity for restricted stock, restricted stock units, deferred stock units and performance units is summarized as follows:
(In millions, except per share amounts)
Number of
Shares
 
Weighted Average
Grant-Date Fair
Value
Balance at September 29, 2017
0.9

 
$
75.37

Granted
0.1

 
109.16

Vested (1)

 
74.62

Cancelled or expired
(0.1
)
 
84.96

Balance at December 29, 2017
0.9

 
$
79.38


(1) 
The vested shares were not material for disclosure.
As of December 29, 2017, unrecognized compensation expense totaling $32.7 million was related to awards of restricted stock, restricted stock units, deferred stock units and performance units granted under the Company's employee stock plans. This unrecognized share-based compensation expense is expected to be recognized over a weighted average period of 2.0 years.